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Background: Keratosis pilaris (KP) is a keratinization disorder 
that is characterized by follicular hyperkeratosis, with 
surrounding erythema. Topical treatments are widely used, 
but their effects are limited. Objective: To evaluate the 
effectiveness of the Q-switched 1064-nm Nd:YAG laser for 
the treatment of KP. Methods: Total of 12 patients with KP 
were treated with a Q-switched 1064-nm Nd:YAG laser. Ten 
sessions of laser treatment were delivered once every two 
weeks. The entire lesions were treated with the following 
laser settings: 4.0∼5.0 J/cm
2, 4-mm spot size, and three 
passes. Two dermatologists' clinical evaluations and patients' 
satisfaction were assessed between before treatment (base-
line) and at 1 month after the last treatment. Results: Eleven 
of the twelve patients showed more than grade 2 (>25%) 
improvement in texture and dyspigmentation in KP lesions, 
respectively. A half of the patients (50%) showed more than 
50% improvement in the skin texture. Regarding dyspig-
mentation, five patients (41.7%) showed more than 50% 
improvement. Eleven out of twelve participants were 
satisfied (>25% of the Patients’ self assessment) with the 
procedure. No significant adverse effect was observed. Con-
clusion: Although the Q-switched 1064-nm laser treatment 
may not be the first line therapy for KP, it might be a new 
treatment option for the patients with recalcitrant KP. (Ann 
Dermatol 23(3) 293∼298, 2011)
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INTRODUCTION
Keratosis pilaris (KP) is a common inherited disorder of 
follicular hyperkeratosis. It is characterized by small, folli-
culocentric keratotic papules that may have surrounding 
erythema
1. The small papules impart a stippled appea-
rance to the skin, resembling gooseflesh. This condition 
can be cosmetically very disturbing, especially in the 
teenagers or female patients. Topical moisturizers and 
keratolytics containing urea, lactic acid or salicylic acid, 
and topical retinoids can be used for the treatment of 
KP
2,3. However, their effect and usefulness can be limited, 
due to short lasting effect and irritation. Therefore, there is 
a need for new and effective treatment options for the 
patients with KP who did not improve by the ordinary 
treatment. Recently, several studies in which keratosis 
rubra pilaris, a variant of KP, has been treated with pota-
ssium titanyl phosphate laser
4 and pulsed dye laser, were 
reported
5. 
We tried to evaluate the clinical response of KP to the 
Q-switched 1064-nm Nd:YAG laser treatment, with regard 
to improvement in dyspigmentation and skin roughness. 
In addition, histopathologic evaluation, before and after 
treatment, was performed in two patients, and the adverse 
effects and treatment tolerability were assessed.
MATERIALS AND METHODS
Patients 
This study was a pilot study to investigate the effect of the 
Q-switched Nd:YAG laser treatment on KP. Twelve female 
Korean patients with KP were enrolled. All patients were 
previously treated with topical agents, such as emollients, J Park, et al
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Table 1. Summary of the clinical outcome
Patients Age Sex Site
Clinical evaluation (Grade) Patients' self
assessment Texture Dyspigmentation
 1 28 F Upper arm Grade 3 Grade 2 Satisfied
 2 33 F Lower leg Grade 2 Grade 3 Satisfied
 3 25 F Thigh Grade 4 Grade 4 Very satisfied 
 4 18 F Upper arm  Grade 1 Grade 2 Slightly satisfied
 5 29 F Back  Grade 3 Grade 3 Very satisfied 
 6 32 F Upper arm Grade 3 Grade 2 Satisfied
 7 35 F Upper arm  Grade 2 Grade 2 Slightly satisfied
 8 24 F Arm  Grade 4 Grade 4 Very satisfied 
 9 22 F Upper arm  Grade 2 Grade 2 Slightly satisfied
10 21 F Thigh  Grade 2 Grade 3 Satisfied 
11 27 F Arm  Grade 2 Grade 1 Unsatisfied 
12 22 F Arm  Grade 3 Grade 2 Satisfied
Grade 1: <25%, Grade 2: 25∼50%, Grade 3: 51∼75%, and Grade 4: >75% improvement. Unsatisfied: <25%, Slightly satisfied:
25∼50%, Satisfied: 51∼75%, and Very satisfied: >75% improvement.
retinoids and keratolytics, but their effectiveness was 
limited. All of the patients were female and the mean age 
of the patients was 26.3 years (range: 18 to 35 years). All 
of the patients had bilateral symmetrical lesions on the 
extensor surfaces of the arms or legs and on the trunk. 
Before the first treatment, detailed information about the 
laser treatment, including risks, benefits and potential 
complications, was given to all enrolled patients. This 
study was approved by the Institutional Review Board at 
the Chung-Ang University Hospital. Written informed con-
sent was obtained from all patients prior to treatment.
Procedure 
The lesions were treated using a Q-switched 1064-nm 
Nd:YAG laser (MedLite
TM C6; Hoya ConBio Inc., Fremont, 
CA), without local anesthesia. Ten sessions of Q-switched 
1064-nm Nd:YAG laser treatment were delivered once 
every two weeks. All lesions were treated with the follow-
ing laser settings: 4.0∼5.0 J/cm
2, 4-mm spot size, 10 Hz 
and three passes, with appropriate overlapping of the 
laser, until a clinical end point of mild erythema and some 
petechiae were observed. All subjects were also instructed 
to avoid sun exposure and to apply broad- spectrum 
sunscreen during and after the treatment.
Evaluation 
1) Clinical improvement
A photograph of each patient was taken with a digital 
camera (EOS 40D, Canon, Japan), before each treatment 
session and two weeks after the last treatment. Clinical 
improvement was evaluated 1 month after the last treat-
ment, using the photographic data. Two independent, ex-
perienced dermatologists evaluated the clinical improve-
ment as seen on digital photographs taken prior to the 
treatment (baseline) and at 1 month after the last treatment, 
using a quartile grading scale (Grade 1, <25%; Grade 2, 
25∼50%; Grade 3, 51∼75%; and Grade 4, >75% 
improvement) on two categories: skin texture (including 
the decrease in papules) and dyspigmentation (erythema 
and hyperpigmentation). During the study, patients were 
asked to report any adverse symptoms (e.g. pain, hyper-
pigmentation, hypopigmentation, crusting, edema, erythema, 
and scarring). At the end of the study, the participants 
documented their degree of satisfaction according to four 
graded-scales of very satisfied (>75%), satisfied (51∼
75%), slightly satisfied (25∼50%), and unsatisfied (<25%). 
2) Histopathologic changes 
In order to evaluate the histopathologic changes, three- 
millimeter punch biopsies from the KP lesioned skin were 
obtained under local anesthesia from 2 patients with 
interfollicular hyperpigmentation, before the treatment 
and 1 month after the last treatment. Haematoxylin and 
Eosin (H&E) stain was used for studying the general 
histopathological changes in the KP lesioned skin. 
3) Adverse effects
At each visit and between visits, patients were assessed for 
adverse effects, including erythema, edema, purpura, 
blistering, pigmentary changes, and scarring.
RESULTS
Clinical improvement
All of 12 patients completed this study, each undergoing 
ten sessions of Q-switched 1064-nm Nd:YAG laser treat-
ment. After the ten sessions of treatment, the comparisons 
made by two independent dermatologists, between 
baseline and post-treatment photographs, showed that 
there was mild to marked improvement in all patients. In A Study of 1064-nm QSNY Laser Treatment in KP
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Fig. 2. A 18-year old female patient with keratosis pilaris (Patient 5) showed Grade 3 improvement in the skin texture and Grade
3 improvement in dyspigmentation. The patients’ self assessment was ‘very satisfied’ (>75% improvement). (a) Before the first treatment
and (b) one month after the last treatment.
Fig. 1. A 18-year old female patient 
with keratosis pilaris (Patient 4) 
showed Grade 1 improvement in the
skin texture and Grade 2 improve-
ment in dyspigmentation. The patients’
self assessment was ‘slightly satis-
fied’ (25∼50% improvement). (a) 
Before the first treatment and (b) one 
month after the last treatment.
the skin texture, two patients showed >75% improve-
ment; four showed 51∼75% improvement; five showed 
25∼50% improvement; and only one showed <25% 
improvement (i.e. unsatisfied with the treatment). Regarding 
dyspigmentation,  two patients showed >75% improve-
ment; three showed 51∼75% improvement, five showed 
25∼50% improvement; and only one showed <25% 
improvement. On the subjective self-assessments, three 
patients were slightly satisfied, five were satisfied, three 
were very satisfied, and one was unsatisfied (Table 1). 
Photographs showing clinical improvement after laser 
treatment were presented in Fig. 1, 2 and 3.
Histopathologic changes
Biopsy specimens were taken from skin on the back of 
patient 5 and the arm of patient 11. Before treatment, the 
general histopathological features of the KP specimens 
showed mild hyperkeratosis, perivascular mononuclear 
cell infiltration, and follicular plugging (Fig. 4a). After 
treatment, the aspect of the epidermis normalized, and 
follicular plugging mostly disappeared (Fig. 4b). 
Adverse effects
Treatments were well tolerated without topical anes-
thetics. There were no significant adverse effects, such as J Park, et al
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Fig. 3. A 24-year old female patient 
with keratosis pilaris (Patient 8) 
showed Grade 4 improvement in the
skin texture and Grade 4 improve-
ment in dyspigmentation. The patients`
self assessment was ‘very satisfied’
(>75% improvement). (a) Before the 
first treatment and (b) one month 
after the last treatment.
Fig. 4. Skin biopsy taken from the skin on the back of Patient 5. (a) Before the first treatment and (b) one month after the last treatment.
The features of mild hyperkeratosis, perivascular mononuclear cell infiltration and follicular plugging improved after treatment (H&E,
×100).
hypopigmentation, crusting, infection, long-standing ery-
thema, scarring, or blistering. However, some patients 
complained of a stinging sensation during the laser treat-
ment, and of transient erythema after treatment. One 
patient complained of hyperpigmentation on the KP 
lesions after treatment. With time, however, hyperpig-
mented lesions improved without any procedures.  
DISCUSSION
The KP disorder is characterized by follicular hyperkeratosis 
expressed as grouped folliculocentric keratotic papules, 
with a variable degree of perifollicular erythema
1. The 
disorder most commonly affects the extensor aspects of 
the upper arms, legs, and buttocks. Patients with KP are 
generally asymptomatic, but occasionally may be pru-
ritic
6. Other common complaints include poor cosmetic A Study of 1064-nm QSNY Laser Treatment in KP
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appearance and persistent rough-textured skin, which may 
cause psychological distress. Treatment is usually with 
keratolytics, topical retinoids, as well as emollients
2,3. 
Control of the inflammation by topical corticosteroids also 
has been reported in KP
4. However, these preparations, 
i.e. keratinolytics or topical retinoids, may aggravate the 
associated erythema, due to irritation, and this is limiting 
their value. Therefore, there is a need for new and effec-
tive treatment options for patients with KP who do not 
respond to conventional treatments. The pulsed tunable 
dye laser (PDL) treatment has been shown to be both safe 
and effective for the erythema of KP atrophicans
7,8, which 
is another variant of KP. Recently, several studies of laser 
treatment for keratosis rubra pilaris, a variant of KP, have 
used either the potassium titanyl phosphate laser
4 or the 
pulsed dye laser
5. To date, to the best of the author’s 
knowledge, there have been no published reports on the 
use of the Q-switched 1064-nm Nd:YAG laser therapy in 
the treatment of KP.
The laser device used in this study was the Q-switched 
1064-nm Nd:YAG laser and the treatment parameters 
were short pulse durations (<10 ns), a repetition rate of 
10 Hz and the use of the collimate beam mode
9. Recently, 
this treatment method has been used for the treatment of 
melasma. The treatment parameters used for KP in this 
study were similar to those for melasma, but the energy 
was somewhat lower than that for dermal pigmentary 
lesions, such as nevus of Ota or acquired bilateral nevus 
of Ota-like macules. 
The Q-switched 1064-nm Nd:YAG laser is a selective 
photothermolysis system which targets hemoglobin, water 
and melanin on the dermal tissue
10 and might improve KP 
by dissolving follicular plugging and by improving 
erythema and pigmentation. Therefore, the Nd:YAG laser, 
which targets the water component, can determine 
follicular opening through exfoliation of the follicular 
plugs, subsequently improving the keratotic condition of 
KP. Also, we hypothesized that the 1064-nm of wave-
length can penetrate deeply into the dermis, thus affecting 
the dermal follicular structure and resolving the follicular 
plugging more effectively than the conventional superficial 
chemical peeling agents used for KP treatment. 
Some cases of KP have been associated with distinct 
variants of KP, i.e. erythromelanosis follicularis faciei et 
colli
11 and KP atrophicans
12. Histologically, erythromela-
nosis follicularis faciei et colli showed increased melanin 
contents of the basal layer and the upper dermis, follicular 
plugging, dermal vascular dilatation, congestion and 
perivascular inflammatory infiltration
13. Thus, in erythro-
melanosis follicularis faciei et colli, increased melanin 
pigments and hemoglobin in the papillary dermal vesssels 
could be the chromophores targeted by the Q-switched 
1064-nm Nd:YAG laser treatment. Similarly, after Q- 
switched Nd:YAG laser treatment, keloid and hyper-
trophic scars can also show clinical improvement through 
reduction of pigmentation and hemoglobin
9. However, 
the precise mechanism of the therapeutic effects of the 
Q-switched 1064-nm Nd:YAG laser on KP is still under 
debate. 
In this study, none of the major adverse effects of 
traditional laser treatments, such as permanent hypopig-
mentation, blistering, or scarring, were noted. Further-
more, the pain was tolerable, both during and after the 
procedure, even without topical anesthetics. Although this 
treatment modality requires multiple sessions of treatment 
to get clinical improvement, the improvement was main-
tained even at the 6-month follow-up.
In patients with KP, 1064-nm Nd:YAG laser monotherapy 
may not be the first line of treatment or the treatment of 
choice, but it could provide synergistic therapeutic effects 
when combined with conventional therapy. This treatment 
modality might be helpful, especially in patients reluctant 
to apply the topical agents or in those with adverse effects 
to the topical treatment.
In conclusion, we suggest that the Q-switched 1064-nm 
Nd:YAG laser might be a new promising therapeutic 
option for KP, without significant adverse effects.
However, this study has some limitations, such as the 
small number of patients and the lack of controlled group. 
Further well-controlled trials in a larger sample of patients 
are needed to fully determine the clinical effects of the 
Q-switched 1064-nm Nd:YAG laser on KP. In the future, 
additional studies will be needed to reveal the precise 
mechanism of action of the Q-switched 1064-nm Nd:YAG 
laser on KP.
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